This inventor holds 1 USPTO granted patent. Top assignee: Aktiebolaget Astra. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Innovations in Pharmacology: The Work of Tomas H. Okfelt
Introduction: Tomas H. Okfelt is a notable inventor based in Djursholm, Sweden, recognized for his contributions to the field of pharmacology. With a focus on developing innovative therapeutic solutions, Okfelt holds a patent that addresses important physiological functions.
Latest Patents: Okfelt's patent centers on a Galanin antagonist, a significant advancement in the area of galanin receptor ligands. This patent details new peptides, including Galanin (1-12)-Pro-Substance P(5-11), Galanin (1-12)-Pro-Bradykinin(2-9), Galanin (1-12)-Pro-Pro-Pro-(Leu.sup.5 -Enkephalin (5-1), and Galanin (1-12)-Pro-Lys(.epsilon.-NH-)Pro-(Leu5-Enkephalin (5-1). These peptides and their functional analogues are designed to be utilized in pharmaceutical preparations aimed at treating disorders in mammals that rely on the galanin receptor’s physiological function.
Career Highlights: Okfelt is affiliated with Aktiebolaget Astra, a prominent company known for its pioneering work in pharmaceuticals. His expertise and inventions contribute to the company's innovative portfolio, helping to advance treatments that can significantly impact patient care.
Collaborations: Throughout his career, Tomas H. Okfelt has collaborated with notable coworkers such as Tamas Bartfai and Ulo Langel. These collaborations enhance the research and development processes, leading to more efficient and effective therapeutic solutions.
Conclusion: With one patent to his name, Tomas H. Okfelt stands out as an inventor dedicated to advancing our understanding of pharmacological treatments. His work not only reflects innovation but also underscores the importance of collaboration and research in the field of medicine. His contributions are a vital part of the ongoing quest to improve health outcomes through scientific advancements.